MedPharmPlast Europe elects new President and Board during its annual General Assembly



MedPharmPlast Europe (MPPE), the Brussels based EuPC sector group representing the plastics medical device and pharmaceutical packaging value chain in Europe, elected its new President and Board during the Annual General Assembly 2017 on 30 November in Brussels.

The members unanimously approved James Stern, Global Business Development Manager for Healthcare at Albis, as new MPPE President.

"I am honoured to take over this important position from my predecessor Christian Meusinger from Nemera. He served as President for the last 3½ years and on behalf of MPPE I would like to thank him for his great commitment," stated James Stern. "As new President of MPPE, I am looking forward to continuing our work in representing and highlighting the opinions and concerns of the healthcare industry as we engage together with European regulators to support pragmatic and practical implementation of either new, approved legislation or provide feedback on future proposed legislation in the healthcare space. Our primary role is to create a forum, without agenda, for engagement and communication, thereby ensuring the best possible outcome for all parties involved."

Additionally, Frank De Smedt from Toxikon joined the MPPE Board as new member. The current MPPE Board composition is therefore the following:

  • James Stern – Albis (President)
  • Steve Duckworth – Clariant (Vice-President)
  • Nigel Talboys – Terumo BCT (Regulatory Task Force Chair)
  • Nicholas Berendt – Sealed Air (Member)
  • Joanne Belshaw – Borealis (Member)
  • Jan de Boer – Sabic (Member)
  • Christian Meusinger – Nemera (Member)
  • Frank De Smedt – Toxikon (Member)

The GA was followed by the MPPE public conference to which around 35 experts from the plastics medical device and pharmaceutical packaging value chain in Europe were welcomed. The programme featured expert speakers from the European Commission, research and industry presenting the latest regulatory updates concerning the industry. The topics included updates on regulations and standards for the testing of plastics material, the SCHEER mandate for the guidelines on phthalates, nanomaterial definition, the interface between EU Chemicals Legislation and the new Medical Device Regulation, an update on Titanium Dioxide, and Horizon 2020 funding opportunities for polymer research on medical devices. The event was accompanied by interesting debates and networking sessions.

The next MPPE Conference 2018 will be organised on 5 July, place to be be confirmed soon.

For more information on MPPE, its activities and events, please contact Eva Schneider, Communications Officer, at [email protected].

30-11-2017 MPPE Conference_material - cut version for website.pdf

PDF - 443 Kb

Eva Schneider

Communications Officer,

Get updates in your mailbox

By clicking "Subscribe" I confirm I have read and agree to the Privacy Policy.

About MedPharmPlast Europe

MedPharmPlast Europe is a sector group of EuPC created in 2014 by and for companies involved in the whole supply chain of plastic medical devices and pharmaceutical packaging in Europe. It assists companies in these industry sectors by keeping them informed about the latest developments in European regulations and their impact on the medical device and pharmaceutical packaging plastics value chain. MedPharmPlast Europe also represents the interests of the industry to the European legislators and tries to arrive at regulations that are both workable and protect the patient.


Avenue de Cortenbergh 71 1000 Brussels Belgium

+32 (0)2 739 63 88

[email protected]